Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Interstellar comet 3I/ATLAS isn't an alien spacecraft, astronomers confirm. 'In the end, there were no surprises.' - 2Former Peruvian President Pedro Castillo sentenced for conspiracy
- 3Scientist turns people’s mental images into text using ‘mind-captioning’ technology
- 4Flash flooding causes highways to close to and from Eilat
- 5The Most Paramount Crossroads in Olympic History
- Pat Finn, actor from 'The Middle,' dies at 60 after bladder cancer diagnosis
- Africa's energy giants eye long-term gains on Iran war disruption
- Which European palace do you fantasy about visiting? Vote!
- A Manual for Nations to Head out To
- Like many holiday traditions, lighting candles and fireplaces is best done in moderation
- From Lounge chair to Money: Online Positions That Will Change Your Profession
- Multi-million-euro win in Spanish lottery in doubt due to oversight
- Geomagnetic storm grounds launch of Mars space weather satellites
- Vote in favor of Your #1 BWM Vehicles
